HOFSETH BIOCARE ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

09 Jul 2026 19:19 CEST

Reference is made to the stock exchange announcements by Hofseth BioCare ASA
("HBC" or the "Company") on 28 and 29 June 2026 regarding completion of delivery
of Offer Shares in tranche 2 (the "T2 Offer Shares") where its subject to an
extraordinary general meeting (the "EGM") resolving to inter alia, (i) issue the
T2 Offer Shares in the Private Placement and (ii) amend the terms of the
Company's B-shares ("B-Shares Amendments").

The Board therefore calls for an EGM to be held at the offices of the Company at
Keiser Wilhelms gate 24, Ålesund on 30 July 2026 at 11:00 hours CEST. The
Company has already received voting undertakings from shareholders representing
the necessary majority requirement to approve the T2 Offer Shares transaction
and B-Shares Amendments at the EGM.

For further information, please contact:

Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 93632966
E-mail: investor@hofsethbiocare.no

More information:
Access the news on Oslo Bors NewsWeb site

677948_HBC EGM notice.pdf